RedHill Biopharma RDHL
NASDAQ RDHL
$0.42 -0.04 (-8.70%)
At close: Oct 22, 2026 · 4:00 PM EDT

RedHill Biopharma (RDHL) Non-Current Deffered Revenue (2018 - 2026)

Updated

Analysis

RedHill Biopharma (RDHL) Non-Current Deffered Revenue (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 RedHill Biopharma 2.14 Mn -14.47 Mn - 500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Dec 31, 2025 500,000.00
Jun 30, 2025 500,000.00
Dec 31, 2024 500,000.00
Jun 30, 2024 540,000.00
Dec 31, 2023 540,000.00
Jun 30, 2023 750,000.00
Mar 31, 2023 750,000.00
Dec 31, 2022 750,000.00
Sep 30, 2022 750,000.00
Jun 30, 2022 750,000.00
Mar 31, 2022 750,000.00
Dec 31, 2021 750,000.00
Sep 30, 2021 750,000.00
Jun 30, 2021 750,000.00
Mar 31, 2021 750,000.00
Dec 31, 2020 750,000.00
Sep 30, 2020 500,000.00
Jun 30, 2020 500,000.00
Mar 31, 2020 500,000.00
API Access

RedHill Biopharma Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RDHL&period=max&api_key=YOUR_API_KEY